JPS6067421A - 抗潰瘍剤 - Google Patents

抗潰瘍剤

Info

Publication number
JPS6067421A
JPS6067421A JP58171407A JP17140783A JPS6067421A JP S6067421 A JPS6067421 A JP S6067421A JP 58171407 A JP58171407 A JP 58171407A JP 17140783 A JP17140783 A JP 17140783A JP S6067421 A JPS6067421 A JP S6067421A
Authority
JP
Japan
Prior art keywords
local anesthetic
effects
action
active
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58171407A
Other languages
English (en)
Japanese (ja)
Other versions
JPH045003B2 (no
Inventor
ルデク・ベネス
アンナ・バブロバ
ビーラ・ノサロバ
スボラド・ストルク
アロイス・ボロバンスキイ
ビクター・バウアー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Czech Academy of Sciences CAS
Original Assignee
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Czech Academy of Sciences CAS filed Critical Czech Academy of Sciences CAS
Publication of JPS6067421A publication Critical patent/JPS6067421A/ja
Publication of JPH045003B2 publication Critical patent/JPH045003B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP58171407A 1983-09-13 1983-09-19 抗潰瘍剤 Granted JPS6067421A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333008 DE3333008A1 (de) 1983-09-13 1983-09-13 Pharmazeutische mittel mit antiulceroeser, spasmolytischer und lokalanaesthetischer wirkung

Publications (2)

Publication Number Publication Date
JPS6067421A true JPS6067421A (ja) 1985-04-17
JPH045003B2 JPH045003B2 (no) 1992-01-30

Family

ID=6208945

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58171407A Granted JPS6067421A (ja) 1983-09-13 1983-09-19 抗潰瘍剤

Country Status (6)

Country Link
JP (1) JPS6067421A (no)
BE (1) BE897823A (no)
CH (1) CH654743A5 (no)
DE (1) DE3333008A1 (no)
NL (1) NL8303098A (no)
SE (1) SE462420B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350519B1 (en) 1998-06-03 2002-02-26 Cabot Corporation Particle having an attached halide group and methods of making the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350519B1 (en) 1998-06-03 2002-02-26 Cabot Corporation Particle having an attached halide group and methods of making the same
US6664312B2 (en) 1998-06-03 2003-12-16 Cabot Corporation Particle having an attached halide group and methods of making the same

Also Published As

Publication number Publication date
CH654743A5 (en) 1986-03-14
NL8303098A (nl) 1985-04-01
SE8304818L (sv) 1985-03-09
SE462420B (sv) 1990-06-25
JPH045003B2 (no) 1992-01-30
BE897823A (fr) 1984-01-16
DE3333008C2 (no) 1990-06-21
DE3333008A1 (de) 1985-03-21
SE8304818D0 (sv) 1983-09-08

Similar Documents

Publication Publication Date Title
US5037815A (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
EP0320551A1 (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2 receptor blockers
US4016268A (en) Method of combatting gastric ulceration
JPS6388122A (ja) 吸収および作用が速やかなサリンダツクまたはサリンダツクナトリウムと塩基の併用剤
JP3929618B2 (ja) 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物
AT401468B (de) Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat
JPS62501845A (ja) 制御放出塩化カリウム
JP3122748B2 (ja) イブプロフェン含有解熱鎮痛剤
EP0399051B1 (en) Polyvalent antiinflammatory agent
US3094464A (en) Aspirin-antacid polysiloxane tablet
US5071842A (en) Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
WO1995001780A1 (en) H2 antagonist-alginate combinations
JPS6067421A (ja) 抗潰瘍剤
CA2055661A1 (en) Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
JP3982889B2 (ja) イブプロフェン含有医薬製剤
US3995055A (en) Method for treating peptic ulcers
JP4203170B2 (ja) 医薬組成物
HUT64216A (en) Process for producing cough diminishing medical preparative containing dextrometorphane
JP2001247481A (ja) 医薬組成物
US4062974A (en) Method for treating drepanocytosis
EP0182569B1 (en) Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4H-pyrido[1,2-a]pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages
US3155576A (en) Ulcer therapy composition and method of using same
JPH0250883B2 (no)
US4073928A (en) Therapeutic treatment for viral regional ileitis infection
WO1998057626A1 (en) Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections